Skip to content
Screener

D&A at other companies

3M logo
3MMMM
$335M+15.5%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$902K+3.3%
Biogen logo
BiogenBIIB
$236.1M+21.5%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$4.83M-0.6%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$155M-3.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$537K-20.4%

Other financials

Income statement

See full
Revenue$216.8M+6.9%
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%
EPS (diluted)$0.76+119%

Balance sheet

See full
Cash & equivalents$181.4M+15.4%
Total debt$28.5M-14.2%
Total equity$1.2B-0.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.39B+87.0%
Enterprise value$2.24B+93.9%
P/E89.5×
P/S2.9×+1.3×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The source filing: Rogers Corporation’s 10-Q, filed July 29, 2026.

Filed
Jul 28, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000084748-26-000048
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Operating Activities:
Net income (loss)$18.1$(75.0)
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization26.626.5
Equity compensation expense4.37.9
Deferred income taxes2.3(3.6)
Impairment charges0.271.8
Other non-cash charges, net(0.2)0.4

Item 1. Condensed Consolidated Financial Statements (Unaudited):

FAQ

What is Rogers Corporation's D&A?
Rogers Corporation (ROG) reported D&A of $13.2M in Q2 2026.
How has Rogers Corporation's D&A changed year-over-year?
Rogers Corporation's D&A decreased by 5.0% year-over-year, from $13.9M to $13.2M.
What is the long-term trend for Rogers Corporation's D&A?
Over 4 years (2021 to 2025), Rogers Corporation's D&A has grown at a 5.8% compound annual growth rate (CAGR), from $43.28M to $54.3M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Ask your AI about Rogers Corporation's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude